Cargando…
Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as the causative agent of coronavirus disease 2019 (COVID-19). Although multiple mutations have been observed in SARS-CoV-2, functional analysis of each mutation of SARS-CoV-2 has been limited by the lack of convenient...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015404/ https://www.ncbi.nlm.nih.gov/pubmed/33838744 http://dx.doi.org/10.1016/j.celrep.2021.109014 |
_version_ | 1783673671597948928 |
---|---|
author | Torii, Shiho Ono, Chikako Suzuki, Rigel Morioka, Yuhei Anzai, Itsuki Fauzyah, Yuzy Maeda, Yusuke Kamitani, Wataru Fukuhara, Takasuke Matsuura, Yoshiharu |
author_facet | Torii, Shiho Ono, Chikako Suzuki, Rigel Morioka, Yuhei Anzai, Itsuki Fauzyah, Yuzy Maeda, Yusuke Kamitani, Wataru Fukuhara, Takasuke Matsuura, Yoshiharu |
author_sort | Torii, Shiho |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as the causative agent of coronavirus disease 2019 (COVID-19). Although multiple mutations have been observed in SARS-CoV-2, functional analysis of each mutation of SARS-CoV-2 has been limited by the lack of convenient mutagenesis methods. In this study, we establish a PCR-based, bacterium-free method to generate SARS-CoV-2 infectious clones. Recombinant SARS-CoV-2 could be rescued at high titer with high accuracy after assembling 10 SARS-CoV-2 cDNA fragments by circular polymerase extension reaction (CPER) and transfection of the resulting circular genome into susceptible cells. The construction of infectious clones for reporter viruses and mutant viruses could be completed in two simple steps: introduction of reporter genes or mutations into the desirable DNA fragments (∼5,000 base pairs) by PCR and assembly of the DNA fragments by CPER. This reverse genetics system may potentially advance further understanding of SARS-CoV-2. |
format | Online Article Text |
id | pubmed-8015404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80154042021-04-02 Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction Torii, Shiho Ono, Chikako Suzuki, Rigel Morioka, Yuhei Anzai, Itsuki Fauzyah, Yuzy Maeda, Yusuke Kamitani, Wataru Fukuhara, Takasuke Matsuura, Yoshiharu Cell Rep Report Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as the causative agent of coronavirus disease 2019 (COVID-19). Although multiple mutations have been observed in SARS-CoV-2, functional analysis of each mutation of SARS-CoV-2 has been limited by the lack of convenient mutagenesis methods. In this study, we establish a PCR-based, bacterium-free method to generate SARS-CoV-2 infectious clones. Recombinant SARS-CoV-2 could be rescued at high titer with high accuracy after assembling 10 SARS-CoV-2 cDNA fragments by circular polymerase extension reaction (CPER) and transfection of the resulting circular genome into susceptible cells. The construction of infectious clones for reporter viruses and mutant viruses could be completed in two simple steps: introduction of reporter genes or mutations into the desirable DNA fragments (∼5,000 base pairs) by PCR and assembly of the DNA fragments by CPER. This reverse genetics system may potentially advance further understanding of SARS-CoV-2. The Authors. 2021-04-20 2021-04-01 /pmc/articles/PMC8015404/ /pubmed/33838744 http://dx.doi.org/10.1016/j.celrep.2021.109014 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Report Torii, Shiho Ono, Chikako Suzuki, Rigel Morioka, Yuhei Anzai, Itsuki Fauzyah, Yuzy Maeda, Yusuke Kamitani, Wataru Fukuhara, Takasuke Matsuura, Yoshiharu Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction |
title | Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction |
title_full | Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction |
title_fullStr | Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction |
title_full_unstemmed | Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction |
title_short | Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction |
title_sort | establishment of a reverse genetics system for sars-cov-2 using circular polymerase extension reaction |
topic | Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015404/ https://www.ncbi.nlm.nih.gov/pubmed/33838744 http://dx.doi.org/10.1016/j.celrep.2021.109014 |
work_keys_str_mv | AT toriishiho establishmentofareversegeneticssystemforsarscov2usingcircularpolymeraseextensionreaction AT onochikako establishmentofareversegeneticssystemforsarscov2usingcircularpolymeraseextensionreaction AT suzukirigel establishmentofareversegeneticssystemforsarscov2usingcircularpolymeraseextensionreaction AT moriokayuhei establishmentofareversegeneticssystemforsarscov2usingcircularpolymeraseextensionreaction AT anzaiitsuki establishmentofareversegeneticssystemforsarscov2usingcircularpolymeraseextensionreaction AT fauzyahyuzy establishmentofareversegeneticssystemforsarscov2usingcircularpolymeraseextensionreaction AT maedayusuke establishmentofareversegeneticssystemforsarscov2usingcircularpolymeraseextensionreaction AT kamitaniwataru establishmentofareversegeneticssystemforsarscov2usingcircularpolymeraseextensionreaction AT fukuharatakasuke establishmentofareversegeneticssystemforsarscov2usingcircularpolymeraseextensionreaction AT matsuurayoshiharu establishmentofareversegeneticssystemforsarscov2usingcircularpolymeraseextensionreaction |